Description
Description:
Metformin HCL ER (Royalty) is a white to off-white, capsule-shaped, film-coated tablet designed for once-daily dosing. The extended-release formulation allows for gradual absorption of metformin, minimizing gastrointestinal side effects and improving patient compliance. It works by decreasing hepatic glucose production, increasing insulin sensitivity, and enhancing peripheral glucose uptake, thereby helping to control blood sugar levels effectively.
Key Features:
- Therapeutic Use: Management of type 2 diabetes mellitus, often in combination with diet and exercise.
- Mechanism of Action: Inhibits hepatic gluconeogenesis and improves insulin sensitivity.
- Dosage Form: Extended-release tablets, usually taken once daily.
- Advantages: Reduced gastrointestinal discomfort compared to immediate-release forms, improved compliance, and steady blood glucose control.
Precautions:
- Not suitable for patients with renal impairment, liver disease, or metabolic acidosis.
- Regular monitoring of kidney function is recommended.
- Lactic acidosis is a rare but serious side effect; patients should be advised to seek medical attention if symptoms occur.
Reviews
There are no reviews yet.